Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2007
08/09/2007CA2640277A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
08/09/2007CA2635800A1 Preventive/remedy for urinary calculosis
08/08/2007EP1816138A1 Cyclosporine analogue mixtures and their use as immunomodulating agents
08/08/2007EP1815867A1 Combination drug for treating autoimmune disease
08/08/2007EP1815860A2 Phosphate transport inhibitors
08/08/2007EP1814539A2 Treatment of conditions caused by calcium abnormalities
08/08/2007EP1708994B1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/08/2007EP1441713B1 Modified release tamsulosin tablets
08/08/2007EP1360169B1 Succinate salt of o-desmethyl-venlafaxine
08/08/2007EP1324992B1 Cyclized benzamide neurokinin antagonists for use in therapy
08/08/2007EP1277736B1 Novel bicyclic compounds
08/08/2007EP1113807B1 Cell mediated gene delivery using muscle derived cells for treating muscle- and bone-related injury or dysfunction
08/08/2007EP1039804A4 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation
08/08/2007EP0837129B1 Epimorphin antagonist and process for producing the same
08/08/2007EP0706376B2 Anti-angiogenic compositions and methods of use
08/08/2007CN1330654C Fused bicyclic pyrimidine derivatives
08/08/2007CN1330649C Carbamate-substituted pyrazolopyridines
08/08/2007CN1330370C Stabilized albumin preparaions
08/08/2007CN1330349C Chinese medicine composition for treating urethra infection and preparing method
08/08/2007CN1330303C Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k
08/08/2007CN1330297C Tolterodine tartrate soft capsule and its preparing method
08/08/2007CN101014708A Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1
08/08/2007CN101014356A Oligopeptides for reducing elevated blood urea concentration
08/08/2007CN101011574A Use of an anti-il6 receptor antibody for preparing pharmaceutical composition
08/08/2007CN101011533A Chinese traditional medicine composition for treating kidney-yang deficiency and preparation and quality controlling method thereof
08/08/2007CN101011500A Linaloe kidney-tea bag tea and its preparing process
08/08/2007CN101011497A Health caring medicinal liquor for strengthening kidney
08/08/2007CN101011495A Kidney tonifying pill preparation made of fish air bladder and its preparation
08/08/2007CN101011484A Medicine for treating urinary system infection disease and preparation method of its capsule
08/08/2007CN101011480A Method for overall monitoring kidney-tonifying body-strengthening tablet quality
08/08/2007CN101011471A Chinese medicine for treating prostatitis
08/08/2007CN101011462A Kidney-tea effervescence tablet and its preparing process
08/08/2007CN101011443A Use of cynoglossum amabile in preparation of medicine for treating prostate diseases
08/08/2007CN101011429A Traditional Chinese medicine for treating uremia
08/08/2007CN101011373A Pharmaceutical composition containing L-carnitine and preparation method thereof
08/07/2007US7253295 Chloride channel opener
08/07/2007US7253281 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea
08/07/2007US7253203 Indoline derivatives
08/07/2007US7253199 Azole derivatives and pharmaceutical compositions containing them
08/07/2007US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
08/07/2007US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
08/07/2007US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents
08/07/2007US7253154 Substituted thiazolopyrimidines as xanthine oxidase inhibitors
08/07/2007US7252799 Methods for sterilizing preparations containing albumin
08/07/2007CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties
08/07/2007CA2340636C Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
08/07/2007CA2286304C Pca3, pca3 genes, and methods of use
08/02/2007WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K
08/02/2007WO2007086545A1 Method for screening cell function regulator
08/02/2007WO2007086504A1 Carboxylic acid compound and use thereof
08/02/2007WO2007085203A1 New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease
08/02/2007US20070179187 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
08/02/2007US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example
08/02/2007US20070179099 Methods of cholesterol reduction using isoflavones
08/02/2007US20070179097 GnRH agonist combination drugs
08/02/2007US20070178114 Novel kallikrein gene
08/02/2007US20070178105 FHIT proteins and nucleic acids and methods based thereon
08/02/2007DE202006004962U1 Verwendung von Nisylen, Cepa, Euphrasia, Belladonna und/oder Mercurius solubilis für ein Arzneimittel Use of Nisylen, Cepa, Euphrasia, Belladonna and / or Mercurius solubilis for a drug
08/02/2007DE102006003697A1 Verwendung als Arzneimittel Use as a medicament
08/01/2007EP1813623A1 Purinenucleoside derivative modified in 8-position and medicinal use thereof
08/01/2007EP1813603A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both
08/01/2007EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound
08/01/2007EP1812021A2 Once a day formulation for phosphate binders
08/01/2007EP1812011A1 Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
08/01/2007EP1812002A2 Treatment of mastitis
08/01/2007EP1572071A4 Systems and methods for treating patients with processed lipoaspirate cells
08/01/2007EP1507760B1 Cyanoguanidine prodrugs
08/01/2007EP1480631B1 Methods of treating non-painful bladder disorders using alpha2-delta- subunit calcium channel modulators
08/01/2007EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity
08/01/2007EP1381681B1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
08/01/2007EP1330468B1 Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids
08/01/2007EP1294714B1 Thrombin receptor antagonists
08/01/2007EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents
08/01/2007EP1289929B1 Shortened synthesis of 3,3-diarylpropylamine derivatives
08/01/2007EP1217998B1 Use of (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
08/01/2007CN1329519C Gamma-linolenic acid dry microbial powder enriched with organic celenium and its producing process
08/01/2007CN1329389C Novel compounds and their use
08/01/2007CN1329359C Ether compounds, compositions, and uses thereof
08/01/2007CN101010323A Bicyclononene derivatives as renin inhibitors
08/01/2007CN101010304A Molecular chaperone function regulator
08/01/2007CN101010300A 2-phenylpyridine derivative
08/01/2007CN101010079A Remedy for glomerular diseae
08/01/2007CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
08/01/2007CN101007173A Anti-angiogene compositions and methods of use
08/01/2007CN101007162A Medicine bag containing traditional Chinese medicine for physiotherapy
08/01/2007CN101007152A A preparation method of 'Sanjin' dispersible tablets
08/01/2007CN101007151A Traditional Chinese medicine and its preparation for treating chronic nephritis
08/01/2007CN101007150A A medicine for treating prostatitis
08/01/2007CN101007143A A traditional Chinese medicine for treating prostate diseases
08/01/2007CN101007036A A traditional Chinese medicine capable of decreasing blood sugar and benefiting kidney
08/01/2007CN101007001A Therapeutic methods and compositions involving isoflavones
08/01/2007CN101007000A Therapeutic methods and compositions involving isoflavones
08/01/2007CN101006999A Therapeutic methods and compositions involving isoflavones
08/01/2007CN101006996A A drug for treating calculus in urinary system and hyperuricemia and its preparation method
07/2007
07/31/2007US7250522 Reacting a 5-thio-D-aldohexopyranose derivative with a hydroxyaromatic compound in the presence of a phosphine and an azo reagent; Mitsunobu reaction conditions; useful as an sodium-dependent glucose transporter (SGLT2) inhibitor; beta-selective glycosylation
07/31/2007US7250403 Administration of immunomodulatory polynucleotide microcarrier complexes featuring a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier
07/31/2007US7250262 For the diagnosis and treatment of patients with disorders including anemias
07/31/2007US7250182 Medicament containing Epimedium extract for treatment of prostatic hyperplasia and prostatitis
07/31/2007CA2412596C Cyclic gmp-specific phosphodiesterase inhibitors
07/31/2007CA2398353C Anticancer compound and enantiomer separation method useful for synthesizing said compound